Mary Thistle - 06 Jun 2023 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Reporting relationship: Director
Issuer ticker: TCRT
Reported as of: 06 Jun 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jun 2023, 17:23:17 UTC
Prior SEC filing: 24 Jun 2022
Next SEC filing: 09 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Melinda Lackey, Attorney-in-Fact

Key filing fact

Mary Thistle filed Form 4 for Alaunos Therapeutics, Inc. (TCRT) on 08 Jun 2023.

Key facts

This page summarizes Mary Thistle's Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Jun 2023, 17:23.

Change

Previous filing in this sequence was filed on 24 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TCRT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +100,000
Change %
Price: $0.000000
Shares after: 100,000
Date: 06 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.4800
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One-twelfth of the shares underlying the option vest in equal monthly installments measured from June 6, 2023, with the first vesting occurring on July 6, 2023, subject to the Reporting Person's continued service through each such date.